ArticleMicroorganisms2025
Clinical Features of Multidrug-Resistant Gram-Negative Bacteremia: A Comparative Study of Cancer and Non-Cancer Patients.
Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bacterial profile, antimicrobial resistance patterns and associated factors among cancer patients at Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia.BMC infectious diseases · 2026Article
- Clinical outcomes and risk factors associated with bloodstream infections caused by multidrug-resistant Gram-negative bacteria in hospitalized patients: a prospective cohort study in Libya.Journal of medical microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug-resistant Gram-negative bacteremia (MDR-GNB) is a significant health threat associated with increased morbidity and mortality rates. Patients with cancer are particularly vulnerable to MDR-GNB due to immunosuppression and frequent healthcare exposure. The aim of this study was to evaluate risk factors, 30-day mortality, and outcomes in cancer and non-cancer patients. We conducted a retrospective study of adult patients aged 18 years or older with MDR-GNB who were hospitalized at Ochsner LSU Health-Academic Medical Center between January 2018 and July 2022. We collected data about demographics, comorbidities, cancer diagnosis, causative organisms, infection source, antibiotic therapy, and clinical outcomes. A total of 112 patients with MDR-GNB were included, where 31 patients (27.7%) had cancer and 81 patients (72.3%) did not. Cancer patients were more frequently male and white (74.2% vs. 58.0%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.